Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1194055016 | Hyoscine hydrobromide 150micrograms tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3475161017 | Scopolamine hydrobromide 0.15 mg oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3475162012 | Product containing scopolamine hydrobromide 0.15 milligram/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3484786019 | Product containing scopolamine hydrobromide 0.15 milligram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3567486014 | Product containing only scopolamine hydrobromide 0.15 milligram/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3567487017 | Product containing only scopolamine hydrobromide 0.15 milligram/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3700063017 | Hyoscine hydrobromide 150 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3700064011 | Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3700065012 | Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3700066013 | Scopolamine hydrobromide 150 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 471372019 | Hyoscine hydrobromide 150micrograms tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 725455010 | Hyoscine hydrobromide 150micrograms tablet (substance) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Scopolamine only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | Plays role | Antiemetic therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Scopolamine hydrobromide (product) | false | Inferred relationship | Some | ||
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Hyoscine (product) | false | Inferred relationship | Some | ||
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Scopolamine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Hyoscine hydrobromide (product) | false | Inferred relationship | Some | ||
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Scopolamine hydrobromide (substance) | false | Inferred relationship | Some | ||
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Scopolamine hydrobromide (product) | false | Inferred relationship | Some | ||
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | Scopolamine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | a pour principe actif (attribut) | Scopolamine hydrobromide (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Scopolamine hydrobromide (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 150 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | microgram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value (attribute) | 0.15 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Scopolamine hydrobromide (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely scopolamine hydrobromide 150 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR